Search
-
Gsk Viiv Healthcare Ir Call 30 April 2019
Media
https://www.gsk.com/media/8120/gsk-viiv-healthcare-ir-call-30-april-2019.pdf
First published: 01 June 2022
-
Fuelling Our Future Growth Slides
Media
https://www.gsk.com/media/8119/fuelling-our-future-growth-slides.pdf
First published: 01 June 2022
-
GSK and ViiV Getting Ahead of HIV Together
Media
https://www.gsk.com/media/10566/gsk_viiv-mtm_getting-ahead-of-hiv-together_20230928.pdf
First published: 28 September 2023
-
Gsk Getting Ahead Of Hiv Evnt Presentation 29 Nov 21
Media
https://www.gsk.com/media/7973/gsk_getting_ahead_of_hiv-evnt-presentation-29-nov-21.pdf
First published: 01 June 2022
-
Getting ahead of HIV together transcript
Media
https://www.gsk.com/media/10661/getting-ahead-of-hiv-together-transcript.pdf
First published: 06 October 2023
-
Gsk Hiv Event Transcript 29Nov21
Media
https://www.gsk.com/media/7974/gsk-hiv-event-transcript-29nov21.pdf
First published: 01 June 2022
-
Ms Esg Garges Draft 1Dec21 Final
Media
https://www.gsk.com/media/7969/ms-esg-garges_draft_1dec21_final.pdf
First published: 01 June 2022
-
ViiV Healthcare announces positive Week 48 results in first study to evaluate treatment switch from TAF-containing regimen with three or more drugs to 2-drug regimen of dolutegravir/lamivudine for HIV-1 infection
Media
International AIDS Society Conference on HIV Science demonstrate non-inferior efficacy of Dovato▼ in virally suppressed adults with HIV
https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-positive-week-48-results-in-first-study-to-evaluate-treatment-switch-from-taf-containing-regimen/
First published: 24 July 2019
-
Jp Morgan Final 14 Jan 2020
Media
https://www.gsk.com/media/8105/jp-morgan-final-14-jan-2020.pdf
First published: 01 June 2022
-
Jp Morgan Healthcare Conference Presentation
Media
https://www.gsk.com/media/7959/jp-morgan-healthcare-conference-presentation.pdf
First published: 01 June 2022